{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:03:54Z","timestamp":1792677834588,"version":"4.5.0"},"reference-count":272,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.01351","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T08:57:32Z","timestamp":1530608252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":279,"title":["Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents"],"prefix":"10.3389","volume":"9","author":[{"given":"Giselle C.","family":"de Oliveira Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleydlenne C.","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto J. O.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do S.","family":"de Sousa Cart\u00e1genes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan K. D. B.","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via R. F.","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo M.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emygdia R. R. B.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo S.","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviane M. G.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"de Andrade Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jep.2016.06.023","article-title":"Chemical composition and biological activities of Artemisia judaica essential oil from southern desert of Jordan.","volume":"191","author":"Abu-Darwish","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/632927","article-title":"Evaluation of antimicrobial and wound healing potential of Justicia flava and Lannea welwitschii.","volume":"2013","author":"Agyare","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mycmed.2016.10.004","article-title":"Antifungal activity of acetone extracts from Punica granatum L., Quercus suber L. and Vicia faba L.","volume":"27","author":"Akroum","year":"2017","journal-title":"J. Mycol. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"Azole antifungals: 35 years of invasive fungal infection management.","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/S1676-24442007000500004","article-title":"Candid\u00edase vulvovaginal: fatores predisponentes do hospedeiro e virul\u00eancia das leveduras.","volume":"43","author":"\u00c1lvares","year":"2007","journal-title":"J. Bras. Patol. Med. Lab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.2174\/1389203711209070632","article-title":"Nanobiotechnology: an efficient approach to drug delivery of unstable biomolecules.","volume":"14","author":"Amaral","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/01.WCB.0000080651.64357.C6","article-title":"L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: a clinical and experimental study.","volume":"23","author":"Armengou","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0022-2836(81)90125-X","article-title":"Refinement of human lysozyme at 1.5 angstroms resolution. analysis of non-bonded and hydrogen-bond interactions.","volume":"152","author":"Artymiuk","year":"1981","journal-title":"J. Mol. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mycmed.2014.01.116","article-title":"Synergistic activity between Echinophora platyloba DC ethanolic extract and azole drugs against clinical isolates of Candida albicans from women suffering chronic recurrent vaginitis.","volume":"24","author":"Avijgan","year":"2014","journal-title":"J. Mycol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9790","DOI":"10.1016\/j.bmc.2008.09.064","article-title":"Structure-activity relationship of antibacterial chalcones.","volume":"16","author":"Avila","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/AAC.41.8.1812","article-title":"In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.","volume":"41","author":"Barchiesi","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1704-y","article-title":"Factors related to outcome of bloodstream infections due to Candida parapsilosis complex.","volume":"16","author":"Barchiesi","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1128\/AAC.44.9.2435-2441.2000","article-title":"Interactions between triazoles and amphotericin B against Cryptococcus neoformans.","volume":"44","author":"Barchiesi","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","first-page":"88","article-title":"Overview of albaconazole.","volume":"5","author":"Bartroli","year":"2011","journal-title":"Eur. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","article-title":"A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ejmech.2008.05.010","article-title":"Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.","volume":"44","author":"Batovska","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/15569527.2015.1020544","article-title":"Voriconazole-associated visual disturbances and hallucinations.","volume":"35","author":"Bayhan","year":"2015","journal-title":"Cutan. Ocul. Toxicol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/AAC.48.5.1773-1777.2004","article-title":"Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1874437001105010029","article-title":"Antibiofilm strategies: how to eradicate Candida biofilms.","volume":"5","author":"Bink","year":"2011","journal-title":"Open Mycol. J."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/jof3030046","article-title":"Natural antimicrobial peptides as inspiration for design of a new generation antifungal compounds.","volume":"3","author":"Bondaryk","year":"2017","journal-title":"J. Fungi"},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.micpath.2017.01.037","article-title":"Antimicrobial activity and phytochemical characterization of Carya illinoensis.","volume":"104","author":"Bottari","year":"2017","journal-title":"Microb. Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0924-8579(08)70006-2","article-title":"Epidemiology of candidemia in intensive care units.","volume":"32","author":"Bouza","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1128\/AAC.03045-14","article-title":"Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.","volume":"58","author":"Brucker","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/cmi.12091","article-title":"Two unlike cousins: Candida albicans and Candida glabrata infection strategies.","volume":"15","author":"Brunke","year":"2013","journal-title":"Cell Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00284-016-1039-3","article-title":"Principles of a new protocol for prediction of azole resistance in Candida albicans infections on the basis of ERG11 polymorphisms.","volume":"73","author":"Caban","year":"2016","journal-title":"Curr. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0966-842X(01)02094-7","article-title":"Virulence factors of Candida albicans.","volume":"9","author":"Calderone","year":"2001","journal-title":"Trends Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S1473-3099(02)00371-7","article-title":"Antifungal drug resistance to azoles and polyenes.","volume":"2","author":"Canuto","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"B28","first-page":"130","article-title":"Antifungal agents: mode of action in yeast cells.","volume":"19","author":"Carrillo-Mu\u00f1oz","year":"2006","journal-title":"Rev. Esp. Quimioter."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1080\/13880209.2017.1304427","article-title":"Antimicrobial activity of Buchenavia tetraphylla against Candida albicans strains isolated from vaginal secretions.","volume":"55","author":"Cavalcanti Filho","year":"2017","journal-title":"Pharm. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3923\/pjbs.2010.452.455","article-title":"Antifungal activity of Rosmarinus officinalis and Thymus vulgaris against Aspergillus flavus and A. ochraceus.","volume":"13","author":"Centeno","year":"2010","journal-title":"Pak. J. Biol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijantimicag.2005.12.005","article-title":"Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.","volume":"27","author":"Cernicka","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1128\/AAC.00095-07","article-title":"Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences.","volume":"51","author":"Chamilos","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3906\/biy-1203-41","article-title":"Antimicrobial, antioxidant, and synergistic properties of two nutraceutical plants: Terminalia catappa L. and Colocasia esculenta L.","volume":"37","author":"Chanda","year":"2013","journal-title":"Turk. J. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/138945005774912762","article-title":"Fungal biofilms and antimycotics.","volume":"6","author":"Chandra","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041624","article-title":"Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production.","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1128\/AAC.01510-09","article-title":"Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.","volume":"55","author":"Chaturvedi","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1128\/AAC.48.12.4505-4512.2004","article-title":"CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1.","volume":"48","author":"Chen","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.fgb.2009.06.003","article-title":"Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.","volume":"46","author":"Chen","year":"2009","journal-title":"Fungal Genet. Biol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/j.1326-5377.2007.tb01313.x","article-title":"Antifungal agents.","volume":"187","author":"Chen","year":"2007","journal-title":"Med. J. Aust ."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-12-226","article-title":"Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats.","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057672","article-title":"Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02051","article-title":"A Linear 19-Mer plant defensin-derived peptide acts synergistically with Caspofungin against Candida albicans biofilms.","volume":"8","author":"Cools","year":"2017","journal-title":"Front. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.","volume":"8","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-1164-3","article-title":"Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species.","volume":"16","author":"Correia","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135110","article-title":"New mechanisms of flucytosine resistance in C. glabrata unveiled by a chemogenomics analysis in S. cerevisiae.","volume":"10","author":"Costa","year":"2015","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","article-title":"TAC 1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.","volume":"3","author":"Coste","year":"2004","journal-title":"Eukaryot. Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of antifungal drug resistance.","volume":"5","author":"Cowen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B50","first-page":"169","article-title":"Antif\u00fangicos en el tratamiento de las infecciones sist\u00e9micas: importancia del mecanismo de acci\u00f3n, espectro de actividad y resistencias.","volume":"23","author":"Cuenca-Estrella","year":"2010","journal-title":"Rev. Esp. Quimioter."},{"key":"B51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/21505594.2015.1039885","article-title":"Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.","volume":"6","author":"Cui","year":"2015","journal-title":"Virulence"},{"key":"B52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.copbio.2011.08.007","article-title":"Polyphenols as antimicrobial agents.","volume":"23","author":"Daglia","year":"2012","journal-title":"Curr. Opin. Biotechnol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijantimicag.2008.01.028","article-title":"In vitro activity of terpenes against Candida biofilms.","volume":"31","author":"Dalleau","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-015-0947-2","article-title":"Antifungal activity and mode of action of Thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.","volume":"15","author":"de Castro","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"14418","DOI":"10.3390\/molecules171214418","article-title":"Antifungal activity of Thymus vulgaris L. essential oil and its constituent phytochemicals against Rhizopus oryzae: interaction with ergosterol.","volume":"17","author":"De Lira Mota","year":"2012","journal-title":"Molecules"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17081252","article-title":"Essential oil of Cymbopogon nardus (L.) Rendle: a strategy to combat fungal infections caused by Candida species.","volume":"17","author":"De Toledo","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1469-0691.2009.02707.x","article-title":"Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization.","volume":"15","author":"Delgado","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1086\/313748","article-title":"Introduction to antifungal drugs.","volume":"30","author":"Dismukes","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.colsurfb.2016.11.041","article-title":"Structural, textural and morphological characteristics of tannins from Acacia mearnsii encapsulated using sol-gel methods: applications as antimicrobial agents.","volume":"151","author":"dos Santos","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B60","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1046\/j.1365-2567.2002.01430.x","article-title":"Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells.","volume":"106","author":"Duits","year":"2002","journal-title":"Immunology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1021\/acs.jafc.5b05671","article-title":"Characterization and physicochemical properties of condensed tannins from Acacia catechu.","volume":"64","author":"Duval","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/08959374000140010201","article-title":"Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva.","volume":"14","author":"Edgerton","year":"2000","journal-title":"Adv. Dent. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1130-1406(08)70027-5","article-title":"Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi.","volume":"25","author":"Espinel-Ingroff","year":"2008","journal-title":"Rev. Iberoam. Micol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1130-1406(09)70004-X","article-title":"Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005\u20132009).","volume":"26","author":"Espinel-Ingroff","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1021\/np2002918","article-title":"Biologically active arborinane-type triterpenoids and anthraquinones from Rubia yunnanensis.","volume":"74","author":"Fan","year":"2011","journal-title":"J. Nat. Prod."},{"key":"B66","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11046-013-9638-z","article-title":"Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.","volume":"175","author":"Ferreira","year":"2013","journal-title":"Mycopathologia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1128\/JCM.03044-13","article-title":"Impact of new antifungal breakpoints on antifungal resistance in Candida species.","volume":"52","author":"Fothergill","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/138945005774912744","article-title":"Currently used antimycotics: spectrum, mode of action and resistance occurrence.","volume":"6","author":"Francois","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"B70","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","article-title":"Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.","volume":"42","author":"Franz","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.","volume":"43","author":"Garey","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-579","article-title":"MFS transportome of the human pathogenic yeast Candida albicans.","volume":"9","author":"Gaur","year":"2008","journal-title":"BMC Genomics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.imr.2015.01.003","article-title":"Comparative efficacy of herbal essences with amphotricin B and ketoconazole on Candida albicans in the in vitro condition.","volume":"4","author":"Gavanji","year":"2015","journal-title":"Integr. Med. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1369-5274(98)80087-8","article-title":"Antifungals: mechanism of action and resistance, established and novel drugs.","volume":"1","author":"Georgopapadakou","year":"1998","journal-title":"Curr. Opin. Microbiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1517\/13543780903176407","article-title":"New generation azole antifungals in clinical investigation.","volume":"18","author":"Girmenia","year":"2009","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"B76","doi-asserted-by":"publisher","first-page":"247","DOI":"10.18388\/abp.2014_940","article-title":"Selected mechanisms of molecular resistance of Candida albicans to azole drugs.","volume":"62","author":"Go\u0142\u0105bek","year":"2015","journal-title":"Acta Biochim. Pol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1080\/14786419.2014.1000892","article-title":"Antifungal activity of extracts from Cynomorium coccineum growing wild in Sardinia island (Italy).","volume":"29","author":"Goncalves","year":"2015","journal-title":"Nat. Prod. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/myc.12469","article-title":"Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.","volume":"59","author":"Gon\u00e7alves","year":"2016","journal-title":"Mycoses"},{"key":"B79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1749-6632.1960.tb40891.x","article-title":"The qualitative identification of free amino acids in human vaginal fluid.","volume":"83","author":"Gregoire","year":"1959","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0891-5520(02)00068-5","article-title":"Clinical pharmacology of antifungal compounds.","volume":"17","author":"Groll","year":"2003","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1054-3589(08)60129-5","article-title":"Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.","volume":"44","author":"Groll","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12281-014-0209-7","article-title":"Epidemiology of echinocandin resistance in Candida.","volume":"8","author":"Grossman","year":"2014","journal-title":"Curr. Fungal Infect. Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/AAC.04613-14","article-title":"Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system.","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijantimicag.2006.08.047","article-title":"Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.","volume":"29","author":"Gualco","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00134-008-1338-7","article-title":"Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis.","volume":"35","author":"Guery","year":"2009","journal-title":"Intensive Care Med."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150196","article-title":"Antifungal activity and action mechanism of histatin 5-halocidin hybrid peptides against Candida ssp.","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/43088","article-title":"A peptide antibiotic from human skin.","volume":"387","author":"Harder","year":"1997","journal-title":"Nature"},{"key":"B88","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1107\/S0907444994013521","article-title":"Structure of human diferric lactoferrin refined at 2.2 A resolution.","author":"Haridas","year":"1995","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"B89","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/lam.12711","article-title":"Chemical composition and antifungal activity of Carica papaya Linn. seeds essential oil against Candida spp.","volume":"64","author":"He","year":"2017","journal-title":"Lett. Appl. Microbiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4067\/S0718-16202010000100007","article-title":"The antifungal effect of six commercial extracts of Chilean propolis on Candida spp.","volume":"37","author":"Herrera","year":"2010","journal-title":"Cienc. Investig. Agrar."},{"key":"B91","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.4049\/jimmunol.171.12.6820","article-title":"Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2.","volume":"171","author":"Hertz","year":"2003","journal-title":"J. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.chom.2009.05.002","article-title":"An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans.","volume":"5","author":"Hise","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B93","doi-asserted-by":"publisher","first-page":"39021","DOI":"10.1074\/jbc.M103830200","article-title":"The structure of human -defensin-1: new insights into structural properties of defensins.","volume":"276","author":"Hoover","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"32911","DOI":"10.1074\/jbc.M006098200","article-title":"The structure of human beta-defensin-2 shows evidence of higher order oligomerization.","volume":"275","author":"Hoover","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-14-456","article-title":"Some Strychnos spinosa (Loganiaceae) leaf extracts and fractions have good antimicrobial activities and low cytotoxicities.","volume":"14","author":"Isa","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jac\/dks481","article-title":"Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.","volume":"68","author":"Jiang","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B97","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1590\/S0036-46652012000100004","article-title":"Oral colonization by yeasts in HIV-positive patients in Brazil.","volume":"54","author":"Junqueira","year":"2012","journal-title":"Rev. Inst. Med. Trop. S \u00e3o Paulo"},{"key":"B98","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","article-title":"Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1128\/AAC.00349-06","article-title":"Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.","volume":"50","author":"Katiyar","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B100","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/mmy.39.1.109.116","article-title":"Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei.","volume":"39","author":"Katiyar","year":"2001","journal-title":"Med. Mycol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0974-777X.192969","article-title":"Identification and antifungal susceptibility testing of Candida species: a comparison of Vitek-2 system with conventional and molecular methods.","volume":"8","author":"Kaur","year":"2016","journal-title":"J. Glob. Infect. Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen.","volume":"49","author":"Kim","year":"2011","journal-title":"J. Microbiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/myc.12207","article-title":"Our 2014 approach to candidemia.","volume":"57","author":"Koehler","year":"2014","journal-title":"Mycoses"},{"key":"B104","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi.","volume":"359","author":"Kontoyiannis","year":"2002","journal-title":"Lancet"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/cbdv.201600070","article-title":"Chemical composition and biological activity of Centaurea baseri: new species from Turkey.","volume":"13","author":"K\u00f6se","year":"2016","journal-title":"Chem. Biodivers."},{"key":"B107","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1128\/AAC.00470-08","article-title":"Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.","volume":"53","author":"Krishnakumari","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B108","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00438-004-0984-x","article-title":"A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains.","volume":"271","author":"Kusch","year":"2004","journal-title":"Mol. Genet. Genomics"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3855\/jidc.2442","article-title":"Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana.","volume":"7","author":"Kwamin","year":"2013","journal-title":"J. Infect. Dev. Ctries."},{"key":"B111","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/AAC.01095-08","article-title":"Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.","volume":"53","author":"Lamping","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.fgb.2012.05.007","article-title":"Candida albicans infection inhibits macrophage cell division and proliferation.","volume":"49","author":"Lewis","year":"2012","journal-title":"Fungal Genet. Biol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"149S","DOI":"10.1592\/phco.21.12.149S.34505","article-title":"Rationale for combination antifungal therapy.","volume":"21","author":"Lewis","year":"2001","journal-title":"Pharmacotherapy"},{"key":"B114","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1017\/S0950268805004905","article-title":"Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients.","volume":"134","author":"Li","year":"2006","journal-title":"Epidemiol. Infect."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-46","article-title":"Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.","volume":"13","author":"Li","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5395\/rde.2016.41.2.91","article-title":"Antifungal effects of synthetic human \u03b2-defensin 3-C15 peptide.","volume":"41","author":"Lim","year":"2016","journal-title":"Restor. Dent. Endod."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003079","article-title":"Candida and host determinants of susceptibility to invasive candidiasis.","volume":"9","author":"Lionakis","year":"2013","journal-title":"PLoS Pathog."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1128\/AAC.49.3.1213-1215.2005","article-title":"Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans.","volume":"49","author":"Lo","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B119","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.femsle.2005.06.036","article-title":"Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.","volume":"249","author":"Looi","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"B120","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.42.11.2932","article-title":"Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.","volume":"2","author":"Lopez-Ribot","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B122","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijantimicag.2016.10.021","article-title":"Antifungal effects of phytocompounds on Candida species alone and in combination with fluconazole.","volume":"49","author":"Lu","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00544","article-title":"The naturally occurring host defense peptide, LL-37, and its truncated mimetics KE-18 and KR-12 have selected biocidal and antibiofilm activities against Candida albicans, Staphylococcus aureus, and Escherichia coli in vitro.","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Microbiol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1086\/522427","article-title":"Human lactoferrin-derived peptide\u2019s antifungal activities against disseminated Candida albicans infection.","volume":"196","author":"Lupetti","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1128\/AAC.44.9.2296-2303.2000","article-title":"Transcriptional analyses of antifungal drug resistance in Candida albicans.","volume":"44","author":"Lyons","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","article-title":"Contribution of mutations in the cytochrome P450 14 alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.","author":"Marichal","year":"1999","journal-title":"Microbiology"},{"key":"B127","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/AAC.41.10.2229","article-title":"Molecular biological characterization of an azole-resistant Candida glabrata isolate.","volume":"41","author":"Marichal","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B128","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1128\/AAC.00303-10","article-title":"A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14\u03b1-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.","volume":"54","author":"Martel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B129","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.indcrop.2015.05.067","article-title":"Activity of phenolic compounds from plant origin against Candida species.","volume":"74","author":"Martins","year":"","journal-title":"Ind. Crops Prod."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/247382","article-title":"In vivo anti-Candida activity of phenolic extracts and compounds: future perspectives focusing on effective clinical interventions.","volume":"2015","author":"Martins","year":"","journal-title":"Biomed. Res. Int."},{"key":"B131","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.foodchem.2014.08.096","article-title":"Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L.","volume":"170","author":"Martins","year":"","journal-title":"Food Chem."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0934-8","article-title":"How to treat fungal infections in ICU patients.","volume":"15","author":"Matthaiou","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00134-014-3404-7","article-title":"Resistance of","volume":"40","author":"Maubon","year":"2014","journal-title":"Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms.","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"key":"B135","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-0757.2010.00373","article-title":"Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity.","volume":"54","author":"McCormick","year":"2000","journal-title":"Periodontol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/exd.12004","article-title":"Alternative approaches to antifungal therapies.","volume":"21","author":"Mehra","year":"2012","journal-title":"Exp. Dermatol."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00286","article-title":"It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug.","volume":"3","author":"Mesa-Arango","year":"2012","journal-title":"Front. Microbiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mycmed.2016.09.002","article-title":"Antifungal effects of Lavandula binaludensis and Cuminum cyminum essential oils against Candida albicans strains isolated from patients with recurrent vulvovaginal candidiasis.","volume":"27","author":"Minooeianhaghighi","year":"2017","journal-title":"J. Mycol. Med."},{"key":"B139","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.42.7.1695","article-title":"Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.","volume":"42","author":"Miyazaki","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00885","article-title":"Histatin 5 inhibits adhesion of C. albicans to reconstructed human oral epithelium.","volume":"6","author":"Moffa","year":"2015","journal-title":"Front. Microbiol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1570180814666170213161341","article-title":"Arginine- and lysine-rich peptides: synthesis, characterization and antimicrobial activity.","volume":"14","author":"Mollica","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/jac\/dkg202","article-title":"In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.","volume":"51","author":"Mondello","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B143","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.indcrop.2015.01.033","article-title":"Antifungal activity of Uncaria tomentosa (Willd.) D.C. against resistant non-albicans Candida isolates.","volume":"69","author":"Moraes","year":"2015","journal-title":"Ind. Crops Prod."},{"key":"B144","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/molecules13040790","article-title":"Antimicrobial activity of three Baccharis species used in the traditional medicine of Northern Chile.","volume":"13","author":"Morales","year":"2008","journal-title":"Molecules"},{"key":"B145","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/AAC.42.7.1819","article-title":"Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.","volume":"42","author":"Moran","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B146","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/1389201017666151223123712","article-title":"Antifungal activity of condensed tannins from Stryphnodendron adstringens: effect on Candida tropicalis growth and adhesion properties.","volume":"17","author":"Morey","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167470","article-title":"Inhibition of Candida albicans biofilm formation by the synthetic lactoferricin derived peptide hLF1-11.","volume":"11","author":"Morici","year":"2016","journal-title":"PLoS One"},{"key":"B148","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.","volume":"3","author":"Morschh\u00e4user","year":"2007","journal-title":"PLoS Pathog."},{"key":"B150","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1179\/joc.2011.23.6.319","article-title":"Echinocandins: are they all the same?","volume":"23","author":"Mukherjee","year":"2011","journal-title":"J. Chemother."},{"key":"B151","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1128\/CMR.18.1.163-194.2005","article-title":"Combination treatment of invasive fungal infections.","volume":"18","author":"Mukherjee","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B152","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jep.2012.06.022","article-title":"Pharmacological properties and protein binding capacity of phenolic extracts of some Venda medicinal plants used against cough and fever.","volume":"143","author":"Mulaudzi","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"e569","DOI":"10.1111\/j.1439-0507.2010.01993.x","article-title":"In vitro antifungal activity of coumarin extracted from Loeselia mexicana Brand.","volume":"54","author":"Navarro-Garc\u00eda","year":"2011","journal-title":"Mycoses"},{"key":"B154","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","article-title":"Antifungal agents: spectrum of activity, pharmacology, and clinical indications.","volume":"30","author":"Nett","year":"2016","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B155","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010.","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"key":"B156","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/medicines2030220","article-title":"Potent and synergistic extract combinations from Terminalia catappa, Terminalia mantaly and Monodora tenuifolia against pathogenic yeasts.","volume":"2","author":"Ngouana","year":"2015","journal-title":"Medicines"},{"key":"B157","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/jac\/dkh456","article-title":"Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.","volume":"54","author":"Niimi","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B158","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.mycmed.2012.04.004","article-title":"The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungals drugs.","volume":"22","author":"Noel","year":"2012","journal-title":"J. Mycol. Med."},{"key":"B159","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ijos.2013.97","article-title":"Growth inhibitory response and ultrastructural modification of oral associated candidal reference strains (ATCC) by Piper betle L. extract.","volume":"6","author":"Nordin","year":"2014","journal-title":"Int. J. Oral Sci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/B:BIOM.0000027691.86757.e2","article-title":"The antimicrobial activity of lactoferrin: current status and perspectives.","volume":"17","author":"Orsi","year":"2004","journal-title":"Biometals"},{"key":"B161","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jac\/dkp495","article-title":"Candida spp. bloodstream infection: influence of antifungal treatment on outcome.","volume":"65","author":"Ortega","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B162","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.matlet.2013.11.066","article-title":"Green phytosynthesis of silver nanoparticles using aqueous extract of Manilkara zapota (L.) seeds its inhibitory action against Candida species.","volume":"116","author":"Otari","year":"2014","journal-title":"Mater. Lett."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/jac\/dkq136","article-title":"Candidemia associated with decreased in vitro fluconazole susceptibility: is","volume":"65","author":"Oxman","year":"2010","journal-title":"CandidaJ. Antimicrob. Chemother."},{"key":"B164","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00510410","article-title":"Lysozyme distribution in healthy human skin.","volume":"272","author":"Papini","year":"1982","journal-title":"Arch. Dermatol. Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/AAC.00824-06","article-title":"Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.","volume":"51","author":"Papon","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B166","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B167","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/molecules19011085","article-title":"Invasive fungal infections in the ICU: how to approach, how to treat.","volume":"19","author":"Paramythiotou","year":"2014","journal-title":"Molecules"},{"key":"B169","first-page":"165","article-title":"Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.","volume":"11","author":"Pasqualotto","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"B170","doi-asserted-by":"publisher","first-page":"i19","DOI":"10.1093\/jac\/dkm428","article-title":"New and emerging treatments for fungal infections.","volume":"61","author":"Pasqualotto","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01391","article-title":"Clinical appearance of oral Candida infection and therapeutic strategies.","volume":"6","author":"Patil","year":"2015","journal-title":"Front. Microbiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1128\/JCM.40.5.1831-1833.2002","article-title":"In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.","volume":"40","author":"Perea","year":"","journal-title":"J. Clin. Microbiol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1128\/AAC.46.6.1695-1703.2002","article-title":"Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.","volume":"46","author":"Perea","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B174","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cbi.2014.10.023","article-title":"Evaluation of anticandidal and antioxidant activities of phenolic compounds from Pyrostegia venusta (Ker Gawl.) Miers.","volume":"224","author":"Pereira","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"B175","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin class antifungal drugs.","volume":"10","author":"Perlin","year":"2007","journal-title":"Resist. Updat."},{"key":"B176","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs.","volume":"6","author":"Perlin","year":"2011","journal-title":"Future Microbiol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12831","article-title":"Mechanisms of echinocandin antifungal drug resistance.","volume":"1354","author":"Perlin","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B178","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1586\/eri.09.18","article-title":"Antifungal drug resistance mechanisms.","volume":"7","author":"Perman","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B179","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijantimicag.2007.03.009","article-title":"Recent advances in antifungal chemotherapy.","volume":"30","author":"Petrikkos","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B180","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101510","article-title":"Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the prospective antifungal therapy (PATH) registry 2004\u20132008.","volume":"9","author":"Pfaller","year":"2014","journal-title":"PLoS One"},{"key":"B182","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.diagmicrobio.2010.06.015","article-title":"Variation in Candida spp. distribution and antifungal resistance rates among blood stream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).","volume":"68","author":"Pfaller","year":"","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.","volume":"48","author":"Pfaller","year":"","journal-title":"J. Clin. Microbiol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive Candidiasis: a persistent public health problem.","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B185","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1128\/JCM.00308-13","article-title":"Echinocandin and triazole antifungal susceptibility profiles of opportunistic yeast and mould clinical isolates (2010\u20132011): application of new CLSI clinical breakpoints and epidemiological cutoff values to characterize geographic and temporal trends of antifungal resistance.","volume":"51","author":"Pfaller","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/14728214.2011.607811","article-title":"Addressing current medical needs prevention in invasive fungal infection agents treatment with new antifungal, formulations strategies","volume":"16","author":"Pitman","year":"2011","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"B187","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0074-7696(04)42005-1","article-title":"Multidrug resistance in yeast Candida.","volume":"242","author":"Prasad","year":"2005","journal-title":"Int. Rev. Cytol."},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00202","article-title":"Efflux pump proteins in antifungal resistance.","volume":"5","author":"Prasad","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B189","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-3-319-25304-6_14","article-title":"\u201cAntifungals: mechanism of action and drug resistance,\u201d in","author":"Prasad","year":"2016","journal-title":"Yeast Membrane Transporter Advances in Experimental Medicine and Biology"},{"key":"B190","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1574-6968.1999.tb08798.x","article-title":"CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole.","volume":"180","author":"Puri","year":"1999","journal-title":"FEMS Microbiol. Lett."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1128\/IAI.00743-12","article-title":"A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesis.","volume":"81","author":"Raman","year":"2013","journal-title":"Infect. Immun."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.4014\/jmb.1402.02056","article-title":"Phenylpropanoids of plant origin as inhibitors of biofilm formation by Candida albicans.","volume":"24","author":"Raut","year":"2014","journal-title":"J. Microbiol. Biotechnol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/1040841X.2011.585606","article-title":"Oral candidosis\u2013clinical challenges of a biofilm disease.","volume":"37","author":"Rautemaa","year":"2011","journal-title":"Crit. Rev. Microbiol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mycmed.2014.01.004","article-title":"Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.","volume":"24","author":"Razzaghi-Abyaneh","year":"2014","journal-title":"J. Mycol. Med."},{"key":"B195","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000207196","article-title":"Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties \u2013 an overview.","volume":"16","author":"Reichling","year":"2009","journal-title":"Forsch. Komplementmed."},{"key":"B196","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00253-013-5425-5","article-title":"ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility.","volume":"98","author":"Ren","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/AAC.02603-14","article-title":"In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.","volume":"58","author":"Ricardo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1040841X.2014.974500","article-title":"Novel strategies to fight Candida species infection.","volume":"10","author":"Rodrigues","year":"2014","journal-title":"Crit. Rev. Microbiol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"231","DOI":"10.17921\/2447-8938.2012v14n4p25p","article-title":"Composi\u00e7\u00e3o qu\u00edmica e atividade do \u00f3leo essencial de Origanum vulgare sobre fungos fitopatog\u00eanicos.","volume":"14","author":"Romero","year":"2012","journal-title":"UNOPAR Cien. Ci\u00eanc. Biol. Sa\u00fade."},{"key":"B200","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MD.0b013e3181e9441b","article-title":"Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.","volume":"89","author":"Safdar","year":"2010","journal-title":"Medicine"},{"key":"B201","first-page":"257","article-title":"The major facilitator superfamily.","volume":"1","author":"Saier","year":"1999","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1699-0463.1997.tb05097.x","article-title":"The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.","volume":"105","author":"Samaranayake","year":"1997","journal-title":"Apmis"},{"key":"B203","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.colsurfb.2003.11.007","article-title":"Surface activity of thymol: implications for an eventual pharmacological activity.","volume":"34","author":"S\u00e1nchez","year":"2004","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2016.00011","article-title":"Emerging threats in antifungal-resistant fungal pathogens.","volume":"3","author":"Sanglard","year":"2016","journal-title":"Front. Med."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","article-title":"Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.","volume":"9","author":"Sanglard","year":"2009","journal-title":"FEMS Yeast Res."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1128\/AAC.45.4.1174-1183.2001","article-title":"Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.","volume":"45","author":"Sanglard","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B206","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","article-title":"The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.","volume":"43","author":"Sanglard","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B207","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/AAC.47.8.2404-2412.2003","article-title":"Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.","volume":"47","author":"Sanglard","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B208","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"B209","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact.","volume":"58","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"B210","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B211","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1590\/S0074-02762002000200019","article-title":"Multicenter Brazilian study of oral Candida species isolated from AIDS patients.","volume":"97","author":"Sant\u2019Ana Pde","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"B212","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.eujim.2013.06.001","article-title":"Trypanocide, cytotoxic, and anti-Candida activities of natural products: Hyptis martiusii Benth.","volume":"5","author":"Santos","year":"2013","journal-title":"Eur. J. Integr. Med."},{"key":"B213","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.","volume":"62","author":"Sardi","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.1074\/jbc.M108830200","article-title":"The solution structures of the human \u03b2-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus.","volume":"277","author":"Schibli","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B215","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature09674","article-title":"Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1.","volume":"469","author":"Schroeder","year":"2011","journal-title":"Nature"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004211","article-title":"Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes.","volume":"10","author":"Schwarzmuller","year":"2014","journal-title":"PLoS Pathog."},{"key":"B217","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.archoralbio.2016.08.030","article-title":"Review of flavonoids: a diverse group of natural compounds with anti-Candida albicans activity in vitro.","volume":"76","author":"Seleem","year":"2017","journal-title":"Arch. Oral Biol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans.","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science"},{"key":"B219","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1601-0825.2007.01424.x","article-title":"Biofilm lifestyle of Candida: a minireview.","volume":"14","author":"Seneviratne","year":"2008","journal-title":"Oral Dis."},{"key":"B220","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1128\/AAC.49.7.2994-2996.2005","article-title":"In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.","volume":"49","author":"Serena","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1099\/jmm.0.047852-0","article-title":"In vitro antifungal activity of the flavonoid baicalein against Candida species.","volume":"61","author":"Serpa","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"B222","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-6515-1_5","article-title":"\u201cSystemic antifungal agents: current status and projected future developments,\u201d in","author":"Seyedmousavi","year":"2017","journal-title":"Methods in Molecular Biology"},{"key":"B223","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/187152109788680199","article-title":"Plant natural products as a potential source for antibacterial agents: recent trends.","volume":"8","author":"Shahid","year":"2009","journal-title":"Anti Infect. Agents Med. Chem."},{"key":"B224","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijantimicag.2014.05.017","article-title":"Utilising polyphenols for the clinical management of Candida albicans biofilms.","volume":"44","author":"Shahzad","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B225","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/MMBR.00045-10","article-title":"Regulatory circuitry governing fungal development, drug resistance, and disease.","volume":"75","author":"Shapiro","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B226","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mycmed.2015.03.008","article-title":"Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans.","volume":"25","author":"Sharifzadeh","year":"2015","journal-title":"J. Mycol. Med."},{"key":"B227","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/0970-9290.183135","article-title":"Antimicrobial efficacy of three medicinal plants Glycyrrhiza glabra, Ficus religiosa, and Plantago major on inhibiting primary plaque colonizers and periodontal pathogens: an in vitro study.","volume":"27","author":"Sharma","year":"2016","journal-title":"Indian J. Dent. Res."},{"key":"B228","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.mycmed.2016.04.004","article-title":"Anti-Candida activity of geraniol involves disruption of cell membrane integrity and function.","volume":"26","author":"Sharma","year":"2016","journal-title":"J. Med. Mycol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"254","DOI":"10.29333\/ejgm\/82217","article-title":"Antifungal drug resistance in Candida species.","volume":"10","author":"Sheikh","year":"2013","journal-title":"Eur. J. Gen. Med."},{"key":"B230","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1128\/AAC.00999-10","article-title":"Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum.","volume":"55","author":"Shields","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B231","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/fmb.12.28","article-title":"Invasive fungal infections in solid organ transplant recipients.","volume":"7","author":"Shoham","year":"2012","journal-title":"Future Microbiol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/157340611797928488","article-title":"Antibacterial activity of thyme and lavender essential oils.","volume":"7","author":"Sienkiewicz","year":"2011","journal-title":"Med. Chem."},{"key":"B233","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1093\/jac\/dkq354","article-title":"Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.","volume":"65","author":"Siikala","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1128\/EC.3.6.1391-1397.2004","article-title":"Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism.","volume":"3","author":"Silver","year":"2004","journal-title":"Eukaryot. Cell"},{"key":"B235","doi-asserted-by":"publisher","first-page":"R717","DOI":"10.1016\/j.cub.2008.07.014","article-title":"Candida biofilms: is adhesion sexy?","volume":"18","author":"Soll","year":"2008","journal-title":"Curr. Biol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.4049\/jimmunol.174.8.4870","article-title":"Differential regulation of beta-defensin expression in human skin by microbial stimuli.","volume":"174","author":"Sorensen","year":"2005","journal-title":"J. Immunol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1128\/AAC.01177-15","article-title":"Candida parapsilosis resistance to fluconazole: molecular mechanisms and in vivo impact in infected Galleria mellonella larvae.","volume":"59","author":"Souza","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00336","article-title":"Antifungal therapy for systemic mycosis and the nanobiotechnology era: improving efficacy, biodistribution and toxicity.","volume":"8","author":"Souza","year":"2017","journal-title":"Front. Microbiol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1155\/2013\/204237","article-title":"Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.","volume":"2013","author":"Spampinato","year":"2013","journal-title":"Biomed Res. Int."},{"key":"B240","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcis.2014.09.023","article-title":"A new class of pegylated plasmonic liposomes: synthesis and characterization.","volume":"437","author":"Stiufiuc","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"B241","doi-asserted-by":"crossref","first-page":"547","DOI":"10.18388\/abp.2013_2019","article-title":"Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.","volume":"60","author":"Strzelczyk","year":"2013","journal-title":"Acta Biochim. Pol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0123-9392(11)70080-7","article-title":"Anti-Candida albicans activity, cytotoxicity and interaction with antifungal drugs of essential oils and extracts from aromatic and medicinal plants.","volume":"15","author":"Tangarife-Casta\u00f1o","year":"2011","journal-title":"Infectio"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00595","article-title":"Phytochemical characterization of Terminalia catappa Linn. extracts and their antifungal activities against Candida spp.","volume":"8","author":"Ter\u00e7as","year":"2017","journal-title":"Front. Microbiol."},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00298","article-title":"Antifungal drug susceptibility of Candida species isolated from HIV-positive patients recruited at a public hospital in S\u00e3o Lu\u00eds, Maranh\u00e3o, Brazil.","volume":"8","author":"Ter\u00e7as","year":"2017","journal-title":"Front. Microbiol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/1750-3841.13672","article-title":"Correlation between antimicrobial, antioxidant activity, and polyphenols of alkalized\/ non alkalized cocoa powders.","volume":"82","author":"Todorovic","year":"2017","journal-title":"J. Food Sci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.4049\/jimmunol.1203239","article-title":"\u03b2-Defensin 1 plays a role in acute mucosal defense against Candida albicans.","volume":"194","author":"Tomalka","year":"2015","journal-title":"J. Immunol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1389203053027520","article-title":"The cathelicidins \u2013 structure, function and evolution.","volume":"6","author":"Tomasinsig","year":"2005","journal-title":"Curr. Protein Pept. Sci."},{"key":"B248","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2958.2008.06143.x","article-title":"The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata.","volume":"68","author":"Torelli","year":"2008","journal-title":"Mol. Microbiol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.biomed.2012.12.004","article-title":"Study of Candida albicans and its interactions with the host: a mini review.","volume":"3","author":"Tsai","year":"2013","journal-title":"BioMedicine"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017755","article-title":"Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates.","volume":"6","author":"Tsai","year":"2011","journal-title":"PLoS One"},{"key":"B251","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1128\/AAC.00926-08","article-title":"Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.","volume":"53","author":"Tsao","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B252","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/ph4010169","article-title":"Pathogenesis and antifungal drug resistance of the human fungal pathogen Candida glabrata.","volume":"4","author":"Tscherner","year":"2011","journal-title":"Pharmaceuticals"},{"key":"B253","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1055\/s-0029-1240799","article-title":"Antifungal activity of the essential oil of Thymus viciosoi against Candida, Cryptococcus, Aspergillus and Dermatophyte species.","volume":"76","author":"Vale-Silva","year":"2010","journal-title":"Planta Med."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2015.10.004","article-title":"The global burden of fungal diseases.","volume":"30","author":"Vallabhaneni","year":"2016","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B255","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000332941","article-title":"The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization.","volume":"4","author":"van der Does","year":"2012","journal-title":"J. Innate Immun."},{"key":"B256","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1128\/AAC.49.11.4608-4615.2005","article-title":"Mechanisms of azole resistance in a clinical isolate of Candida tropicalis.","volume":"49","author":"Vandeputte","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B257","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/ddg.12097","article-title":"Opportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis.","volume":"11","author":"V\u00e1zquez-Gonz\u00e1lez","year":"2013","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"B258","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"B259","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1016\/j.ijcard.2013.12.057","article-title":"Congestive heart failure related to antifungal therapy with itraconazole.","volume":"172","author":"Vollenbroich","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/yea.2925","article-title":"The effect of histatin 5, adsorbed on PMMA and hydroxyapatite, on Candida albicans colonization.","volume":"29","author":"Vukosavljevic","year":"2012","journal-title":"Yeast"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036952","article-title":"Candida albicans-epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process.","volume":"7","author":"W\u00e4chtler","year":"2012","journal-title":"PLoS One"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-9-167","article-title":"Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.","volume":"9","author":"Wang","year":"2009","journal-title":"BMC Microbiol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1099\/jmm.0.46650-0","article-title":"The DNA binding domain of CaNdt80p is required to activate CDR1 involved in drug resistance in Candida albicans.","volume":"55","author":"Wang","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"B264","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/JB.182.2.400-404.2000","article-title":"Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a transregulatory factor.","volume":"182","author":"Wirsching","year":"2000","journal-title":"J. Bacteriol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.drudis.2014.06.009","article-title":"In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules.","volume":"19","author":"Wong","year":"2014","journal-title":"Drug Discov. Today"},{"key":"B266","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1099\/00222615-48-8-721","article-title":"Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme.","volume":"48","author":"Wu","year":"1999","journal-title":"J. Med. Microbiol."},{"key":"B267","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/fsn3.264","article-title":"Phenolic compounds, antioxidant, and antibacterial properties of pomace extracts from four Virginia-grown grape varieties.","volume":"4","author":"Xu","year":"2016","journal-title":"J. Food Sci. Nutr."},{"key":"B268","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10482-010-9516-3","article-title":"Antifungal effects of ellagitannin isolated from leaves of Ocotea odorifera (Lauraceae).","volume":"99","author":"Yamaguchi","year":"2011","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B269","first-page":"79","article-title":"Mechanisms of antifungal agent resistance.","volume":"34","author":"Yang","year":"2001","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1086-6","article-title":"Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy.","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"B271","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.phymed.2011.03.008","article-title":"Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.","volume":"18","author":"Zore","year":"2011","journal-title":"Phytomedicine"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.01351\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T04:35:37Z","timestamp":1571546137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.01351\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":272,"alternative-id":["10.3389\/fmicb.2018.01351"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.01351","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"article-number":"1351"}}